Subsense raises $10M extension for nanoparticle non-surgical BCI platform bringing total to $27M
Summary
Subsense, a San Francisco startup developing nanoparticle-based non-surgical brain-computer interfaces, raised a $10M extension bringing total funding to $27M following positive early technical breakthroughs. The company's nanoparticle platform aims to achieve high-resolution neural recording and stimulation without surgery by introducing particles that self-organize around neurons after minimally invasive delivery. Subsense represents a third paradigm alongside implanted electrodes and external sensors.
Why it matters
Nanoparticle-based BCIs are the most radical departure from conventional neural interface approaches — no surgery, no implanted hardware, yet potentially achieving cellular-resolution neural recording. The $27M total funding is small by BCI standards but enough to demonstrate the core technical feasibility that would trigger a much larger round.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial